Zimmer Biomet Holdings (ZBH) Non Operating Interest Expenses (2011 - 2018)

Zimmer Biomet Holdings has reported Non Operating Interest Expenses for 8 years, with the latest figure at $68.3 million in Q3 2018.

• On a quarterly basis, Non Operating Interest Expenses fell 17.01% year-over-year to $68.3 million in Q3 2018; TTM through Sep 2018 was $303.1 million, a 10.22% decrease from a year earlier, with the FY2017 full-year figure at $327.5 million, down 8.49% from the prior year.
• Non Operating Interest Expenses was $68.3 million for Q3 2018 at Zimmer Biomet Holdings, down from $75.9 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $91.5 million in Q3 2016, with the low at $15.0 million in Q1 2014.
• Average Non Operating Interest Expenses over 5 years is $66.2 million, with a median of $82.3 million recorded in 2017.
• The sharpest annual moves came in 2014 and 2015: Non Operating Interest Expenses decreased 17.58% in 2014, then surged 462.5% in 2015.
• Over 5 years, Non Operating Interest Expenses stood at $16.0 million in 2014, then soared by 462.5% to $90.0 million in 2015, then gained by 0.11% to $90.1 million in 2016, then declined by 11.21% to $80.0 million in 2017, then decreased by 14.62% to $68.3 million in 2018.
• The last three Non Operating Interest Expenses figures came in at $68.3 million (Q3 2018), $75.9 million (Q2 2018), and $78.9 million (Q1 2018), per Business Quant data.